Analysis of the pattern and course of juvenile idiopathic arthritis in children of the Samara Region


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and one of the most frequent childhood chronic diseases. Patients with continuous disease progression (33 to 75%) and insufficient efficiency of various types of basic therapy are currently prevalent in the pattern of JIA. It is important for the physician to predict the outcomes of the disease and to determine the clinical predictors of a long-term adverse JIA outcome. Objective. To study the pattern and course of JIA in children living in the Samara Region to optimize approaches to therapy. Subjects and methods. The gender and age characteristics of patients with JIA were studied. The diagnosis was verified according to the ILAR criteria. The pattern of JIA in the Samara Region was presented. The authors analyzed risk factors for, the mean age at onset of JIA in various types of its course, the involvement of different joints in the pathological process, the activity of JIA, X-ray characteristics and functional class in the most common variants, as well as concomitant diseases. Biological therapy, the mean duration of biological agent (BA) use and the mean age of patients receiving the treatment were analyzed. Results. The presented information on the pattern and course of JIA in the Samara Region, the time of diagnosis and the timing of prescribed therapy, including that with BAs, and the reasons for their discontinuation allow us to apply a differentiated approach to therapy and to evaluate its efficiency and safety.

Full Text

Restricted Access

About the authors

E. A Amosova

Samara State Medical University, Ministry of Health of Russia

Candidate of Medical Sciences

S. V Plakhotnikova

Samara State Medical University, Ministry of Health of Russia

Candidate of Medical Sciences

G. V Santalova

Samara State Medical University, Ministry of Health of Russia

Professor

E. A Borodulina

Samara State Medical University, Ministry of Health of Russia

Email: borodulinbe@yandex.ru
Professor

M. A Davydova

Samara State Medical University, Ministry of Health of Russia

References

  1. Баранов А.А., Алексеева Е.И. Ювенильный артрит. Детская ревматология. Клинические рекомендации для педиатров. М.: ПедиатрЪ, 2013; 117 с. [Baranov A.A., Alekseeva E.I. Yuvenil’nyi artrit. Detskaya revmatologiya. Klinicheskie rekomendatsii dlya pediatrov. M.: Pediatr»», 2013; 117 s. (in Russ.)].
  2. Smolen J.S., Landewe R., Bijlsma J. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017; 76 (6): 96077. doi: 10.1136/annrheumdis-2016-210715
  3. Horneff G. Treatment options with biologics for juvenile idiopathic arthritis. Int J Clin Rheumatol. 2011; 6 (3): 1-19.
  4. Санталова Г.В., Бородулина Е.А., Кудлай Д.А. и др. Ревматические заболевания и туберкулезная инфекция у детей и взрослых. Туберкулез и болезни легких. 2019; 97 (2): 50-5 [Santalova G.V., Borodulina E.A., Kudlay D.A. et al. Rheumatic diseases and tuberculosis infection in children and adults. Tuberculosis and Lung Diseases. 2019; 97 (2): 50-5 (in Russ.)]. https://doi.org/10.21292/2075-1230-2019-97-2-50-55
  5. Bhatt K.H., Karjodkar F.R., Sansare K. et al. Juvenile idiopathic arthritis. Contemp Clin Dent. 2014; 5: 89-91. doi: 10.4103/0976-237X.128677
  6. Giancane G., Consolaro A., Lanni S. et al. Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Rheumatol Ther. 2016; 3 (2): 187-207. DOI: 10.1007/ s40744-016-0040-4
  7. Алексеева Е.И. Ювенильный идиопатический артрит: клиническая картина, диагностика, лечение. Вопросы современной педиатрии. 2015; 14 (1): 78-94 [Alexeeva E.I. Juvenile idiopathic arthritis: clinical picture, diagnosis, treatment. Current Pediatrics. 2015; 14 (1): 78-94 (in Russ.)]. https://doi. org/10.15690/vsp.v14i1.1266
  8. Савостьянов К.В., Алексеева Е.И., Чистяков Д.А. Ассоциация генов, не кодирующих компоненты главного комплекса гистосовместимости, с ювенильным идиопатическим артритом. Вестник РАМН. 2014; 9-10: 83-94 [Savost’anov K.V., Alexeeva E.I., Chistiakov D.A. Contribution OF Non-HLA Genes to Juvenile Idiopathic Arthritis Susceptibility. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk = Annals of the Russian Academy of Medical Sciences. 2014; 9-10: 83-94 (in Russ.)].
  9. Федоров Е.С., Крылов М.Ю., Салугина С.О. и др. Полиморфизмы STAT4 rs7574865 G/T и IRF5 rs2004640 G/T как маркеры предрасположенности к ювенильному идиопатическому артриту. Что может дать генетика для понимания его гетерогенности? Современная ревматология. 2019; 13 (4): 55-60 [Fedorov E.S., Krylov M.Yu., Salugina S.O. et al. STAT4 rs7574865 G/T and IRF5 rs2004640 G/T polymorphisms as markers of predisposition to juvenile idiopathic arthritis. What can genetics give to understand its heterogeneity? Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019; 13 (4): 55-60 (in Russ.)]. DOI: 10/14412/1996-7012-2019-4-55-60
  10. Oen K., Malleson P. N., Cabral D. A. et al. Early predictors of longterm outcome in patients with JRA: subset-specific correlations. JRheumatol. 2003; 30: 585-93.
  11. Насонов Е.Л. Проблемы иммунопатологии ревматоидного артрита: эволюция болезни. Научно-практическая ревматология. 2017; 55 (3): 277-94 [Nasonov E.L. Problems of rheumatoid arthritis immunopathology: evolution of the disease. Rheumatology Science and Practice. 2017; 55 (3): 277-94 (in Russ.)]. https://doi.org/10.14412/1995-4484-2017-277-294
  12. Давыдова М.А. Развитие и прогноз деструктивных изменений суставов у детей с ювенильным идиопатическим артритом. Вопросы практической педиатрии. 2017; 12 (3): 46-53 [Davydovа M.A. Development and prognosis of destructive changes of the joints in children with juvenile idiopathic arthritis. Vopr prakt pediatr = Clinical Practice in Pediatrics. 2017; 12 (3): 46-53 (in Russ.)]. doi: 10.20953/1817-7646-2017-3-46-53
  13. Алексеева Е.И. Ювенильный идиопатический артрит: клиническая картина, диагностика, лечение. Вопросы современной педиатрии. 2015; 14 (1): 78-94 [Alexeeva E.I. Juvenile idiopathic arthritis: clinical picture, diagnosis, treatment. Current Pediatrics. 2015; 14 (1): 78-94 (in Russ.)]. https://doi. org/10.15690/vsp.v14i1.1266
  14. Каледа М.И., Никишина И.П., Костарева О.М. Оптимизация схем лечения системного варианта ювенильного артрита с коррекцией режимов внутривенного введения тоцилизумаба по данным наблюдательного ретроспективного исследования. Научно-практическая ревматология. 2019; 2: 229-34 [Kaleda M.I., Nikishina I.P., Kostareva O.M. Optimization of systemic juvenile arthritis treatment regimens with correction of tocilizumab intravenous administration according to data of observational retrospective study. Rheumatology Science and Practice. 2019; 57 (2): 229-34 (in Russ.)]. https://doi. org/10.14412/1995-4484-2019-229-234
  15. Алексеева Е.И., Валиева С.И., Бзарова Т.М. и др. Клинический случай применения тоцилизумаба у пациента с системным ювенильным идиопатическим артритом. Педиатрическая фармакология. 2016; 13 (4): 390-4 https://doi.org/10.15690/ pf.v13i4.1613
  16. Чижевская И., Беляева Л. Терапия ювенильного идиопатического артрита тоцилизумабом. Наука и инновации. 2019; 2 (192): 76-81 [Chyzheuskaya I., Belyaeva L. Therapy for juvenile idiopathic arthritis with tocilizumab. The Science and Innovations. 2019; 2 (192): 76-81 (in Russ.)]. https:// doi.org/10.29235/1818-9857-2019-2-76-81
  17. Бородулина Е.А., Санталова Г.В., Кудлай Д.А. и др. Мониторинг туберкулезной инфекции у детей с ювенильным идиопатическим артритом, получающих генно-инженерные препараты. Педиатрия. Журнал им. Г.Н. Сперанского. 2019; 98 (2): 209-13 [Boroduiine EA, Sаntаlovа G.V., Kudtay DA E.A. et al. Monitoring of tuberculosis infection in children with juvenile idiopathic arthritis receiving genetically preparations. Pediatria. 2019; 98 (2): 209-13 (in Russ.)]. doi: 10.24110/0031-403X-2019-98-2-209-213

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies